Theravance Biopharma Statistics
Total Valuation
TBPH has a market cap or net worth of $694.73 million. The enterprise value is $402.39 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TBPH has 50.36 million shares outstanding. The number of shares has increased by 0.54% in one year.
Current Share Class | 50.36M |
Shares Outstanding | 50.36M |
Shares Change (YoY) | +0.54% |
Shares Change (QoQ) | +2.05% |
Owned by Insiders (%) | 7.52% |
Owned by Institutions (%) | 43.65% |
Float | 21.89M |
Valuation Ratios
The trailing PE ratio is 53.92 and the forward PE ratio is 28.38.
PE Ratio | 53.92 |
Forward PE | 28.38 |
PS Ratio | 8.86 |
Forward PS | 9.34 |
PB Ratio | 3.09 |
P/TBV Ratio | 3.09 |
P/FCF Ratio | 2.84 |
P/OCF Ratio | 2.84 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 30.88 |
EV / Sales | 5.21 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 1.64 |
Financial Position
The company has a current ratio of 6.70, with a Debt / Equity ratio of 0.21.
Current Ratio | 6.70 |
Quick Ratio | 6.60 |
Debt / Equity | 0.21 |
Debt / EBITDA | n/a |
Debt / FCF | 0.19 |
Interest Coverage | -13.82 |
Financial Efficiency
Return on equity (ROE) is 6.23% and return on invested capital (ROIC) is -8.71%.
Return on Equity (ROE) | 6.23% |
Return on Assets (ROA) | -5.65% |
Return on Invested Capital (ROIC) | -8.71% |
Return on Capital Employed (ROCE) | -9.59% |
Revenue Per Employee | $795,928 |
Profits Per Employee | $134,340 |
Employee Count | 97 |
Asset Turnover | 0.20 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, TBPH has paid $27.05 million in taxes.
Income Tax | 27.05M |
Effective Tax Rate | 67.49% |
Stock Price Statistics
The stock price has increased by +70.52% in the last 52 weeks. The beta is 0.01, so TBPH's price volatility has been lower than the market average.
Beta (5Y) | 0.01 |
52-Week Price Change | +70.52% |
50-Day Moving Average | 11.54 |
200-Day Moving Average | 9.96 |
Relative Strength Index (RSI) | 76.71 |
Average Volume (20 Days) | 443,659 |
Short Selling Information
The latest short interest is 4.12 million, so 8.19% of the outstanding shares have been sold short.
Short Interest | 4.12M |
Short Previous Month | 3.95M |
Short % of Shares Out | 8.19% |
Short % of Float | 18.83% |
Short Ratio (days to cover) | 25.56 |
Income Statement
In the last 12 months, TBPH had revenue of $77.21 million and earned $13.03 million in profits. Earnings per share was $0.26.
Revenue | 77.21M |
Gross Profit | 36.54M |
Operating Income | -35.63M |
Pretax Income | -38.22M |
Net Income | 13.03M |
EBITDA | -33.96M |
EBIT | -35.63M |
Earnings Per Share (EPS) | $0.26 |
Full Income Statement Balance Sheet
The company has $338.80 million in cash and $46.46 million in debt, giving a net cash position of $292.35 million or $5.80 per share.
Cash & Cash Equivalents | 338.80M |
Total Debt | 46.46M |
Net Cash | 292.35M |
Net Cash Per Share | $5.80 |
Equity (Book Value) | 224.85M |
Book Value Per Share | 4.46 |
Working Capital | 311.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $245.02 million and capital expenditures -$239,000, giving a free cash flow of $244.78 million.
Operating Cash Flow | 245.02M |
Capital Expenditures | -239,000 |
Free Cash Flow | 244.78M |
FCF Per Share | $4.86 |
Full Cash Flow Statement Margins
Gross margin is 47.33%, with operating and profit margins of -46.16% and 16.88%.
Gross Margin | 47.33% |
Operating Margin | -46.16% |
Pretax Margin | 51.91% |
Profit Margin | 16.88% |
EBITDA Margin | -43.99% |
EBIT Margin | -46.16% |
FCF Margin | 317.05% |
Dividends & Yields
TBPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.54% |
Shareholder Yield | -0.54% |
Earnings Yield | 1.88% |
FCF Yield | 35.23% |
Analyst Forecast
The average price target for TBPH is $21.33, which is 54.62% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.33 |
Price Target Difference | 54.62% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 26.58% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TBPH has an Altman Z-Score of -0.9 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.9 |
Piotroski F-Score | 6 |